Literature DB >> 15223985

Screening for diabetic retinopathy in France.

N Deb1, G Thuret, B Estour, P Massin, P Gain.   

Abstract

Ocular complications of diabetes, particularly retinopathy, are the major cause of blindness in the working age population in industrialised nations. Laser photocoagulation has shown definite results in reducing visual morbidity with many more likely to benefit if diagnosed early enough. Institution of an efficient screening programme aimed at detecting patients at risk when they can still be effectively treated has been recognised as an urgent priority worldwide. In France, a signatory to the Saint Vincent's Declaration, an analysis of the national healthcare database reveals a gross inadequacy in the current extent of screening for diabetic retinopathy. The possible causative factors have been analysed and the necessary corrective measures, some of which are already under way, have been discussed. Ideally, screening by ophthalmologists at recommended intervals have been advised by national and professional health care associations. This has not been feasible owing to the lack of organised planning and serious manpower deficit caused by a progressive decline in the number of ophthalmologists. Recently, the need for an efficient, widely-available and user-friendly screening tool has led to the evaluation of multifield fundus photography in real time using digital nonmydriatic camera in comparison with more established methods of detecting diabetic retinopathy. Lastly, the future possibility of involving in France non-ophthalmologists like endocrinologists or general practitioner or non medical profession like orthoptists after proper training to meet the necessary manpower shortage has been addressed. Optimal use of telemedicine along with establishment of preferential reference channels for newly discovered cases of sight-threatening cases of retinopathy are public health priority necessary to give to the screening of diabetic retinopathy its full efficiency.

Entities:  

Mesh:

Year:  2004        PMID: 15223985     DOI: 10.1016/s1262-3636(07)70099-x

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  6 in total

1.  Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats.

Authors:  Xiaoping Yu; Zhaoxia Xu; Mantian Mi; Hongxia Xu; Jundong Zhu; Na Wei; Ka Chen; Qianyong Zhang; Kaihong Zeng; Jian Wang; Fang Chen; Yong Tang
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

2.  No loss of chance of diabetic retinopathy screening by endocrinologists with a digital fundus camera.

Authors:  Natacha Germain; Bodgan Galusca; Nilanjana Deb-Joardar; Luc Millot; Pierre Manoli; Gilles Thuret; Philippe Gain; Bruno Estour
Journal:  Diabetes Care       Date:  2011-01-25       Impact factor: 19.112

3.  Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic.

Authors:  Pia Roser; Hannes Kalscheuer; Jan B Groener; Daniel Lehnhoff; Roman Klein; Gerd U Auffarth; Peter P Nawroth; Florian Schuett; Gottfried Rudofsky
Journal:  J Diabetes Res       Date:  2016-01-21       Impact factor: 4.011

Review 4.  Advances in Retinal Imaging and Applications in Diabetic Retinopathy Screening: A Review.

Authors:  Beau J Fenner; Raymond L M Wong; Wai-Ching Lam; Gavin S W Tan; Gemmy C M Cheung
Journal:  Ophthalmol Ther       Date:  2018-11-10

5.  Capturing the clinical decision-making processes of expert and novice diabetic retinal graders using a 'think-aloud' approach.

Authors:  Katie Curran; Nathan Congdon; Tunde Peto; Catherine Dardis; Quan Nhu Nguyen; Tung Thanh Hoang; Finian Bannon; An Luu; Tung Quoc Mai; Van Thu Nguyen; Hue Thi Nguyen; Huong Tran; Hoang Huy Tran; Lynne Lohfeld
Journal:  Eye (Lond)       Date:  2021-05-10       Impact factor: 4.456

Review 6.  The burden and treatment of diabetes in France.

Authors:  Karine Chevreul; Karen Berg Brigham; Clara Bouché
Journal:  Global Health       Date:  2014-02-20       Impact factor: 4.185

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.